Advocacy intelligence hub — real-time data for patient organizations
Starlight Cardiovascular Inc — NA
Al-Quds University — PHASE2, PHASE3
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Merit Medical Systems, Inc. — NA
Coordinación de Investigación en Salud, Mexico — PHASE4
Assiut University — NA
St. Olavs Hospital
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Hamilton Health Sciences Corporation — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
NeoProfen
Lundbeck, Inc.
NeoProfen
(Ibuprofen lysine)Orphan drugstandardLundbeck, Inc.
12.1 Mechanism of Action The mechanism of action through which ibuprofen causes closure of a patent ductus arteriosus (PDA) in neonates is not known. ...
Jean-Michel HASCOET, MD
Maternite Regionale Universitaire NANCY
Amish Jain, MD PhD, MD
MOUNT SINAI HOSPITAL
📍 STANFORD, CA
Christoph Czernik, MD
Charite, Medical University Berlin
Jacob V Aranda, MD, PhD, MD
📍 DETROIT, MI
Se In Sung, M.D.
Samsung Medical Center
Ronald Clyman, MD, M.D
University of California, San Francisco
📍 SAN FRANCISCO, CA